scholarly journals Mechanistic modeling of a human IgG 4 monoclonal antibody (tralokinumab) Fab‐arm exchange with endogenous IgG 4 in healthy volunteers

Author(s):  
Bing Wang ◽  
Jo Goodman ◽  
Lorin K. Roskos
1989 ◽  
Vol 116 (1) ◽  
pp. 99-103 ◽  
Author(s):  
Akihiko Kimura ◽  
Yoshihiro Tamaki ◽  
Tetsuko Kishida ◽  
Masako Fukuda ◽  
Tsutomu Tsuji

Blood ◽  
1985 ◽  
Vol 65 (3) ◽  
pp. 615-619 ◽  
Author(s):  
RA Dunstan ◽  
MB Simpson ◽  
RW Knowles ◽  
WF Rosse

Abstract ABH antigens are present on platelets from individuals of the corresponding red cell phenotype, but the extent to which these antigens are intrinsic or adsorbed remains undefined. To evaluate platelets for intrinsic H substance, an IgM mouse monoclonal antibody against type 2H chain (the intrinsic H structure found on erythrocytes) was labeled with 125I and incubated with platelets from donors of different ABO type. The antibody showed dose-response saturation curves, and binding to platelets paralleled that of the red cell ABO type, with O greater than B greater than A1 greater than A1B greater Oh cells, giving a single factor variance F of 190 (P less than .0005). Passive adsorption of A antigens by platelets has been previously reported. To verify this phenomenon for A and B antigens and to quantitate the elution of A and B antigens from platelets, the following assay system was used. Platelets from group A1 and B donors were incubated in plasma from group O donors, and platelets from group O donors were incubated in plasma from different ABO, Lewis, and presumed secretor-type donors. Human IgG anti-A or anti-B was added to the platelets. The amount of antibody bound was determined with a 125I- labeled mouse monoclonal anti-human IgG. When incubated for 96 hours in group O plasma, group A1 platelets showed a 45% to 50% decrease in binding of anti-A. There was no significant change in the level of type 2H antigen on these platelets during the same incubation period. Group O platelets incubated in A or B plasmas rapidly acquired the antigens, but if returned to their original plasma, 95% of this passively adsorbed antigen eluted off within 18 hours. The maximum uptake of A and B substances was influenced by the Lewis and secretor type of donor plasma. Our present study demonstrates that ABH antigens on platelets consist of type 2H chains, which are presumably intrinsic as when found on red cells, and of passively adsorbed ABH structures, which are presumably type 1H chains.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 4745-4745
Author(s):  
Xiuju Wang ◽  
Songmei Yin ◽  
Liping Ma ◽  
Danian Nie ◽  
Shangfeng Xie ◽  
...  

Abstract Abstract 4745 To observe how did the allogeneic NK cells kill human multiple myeloma cell RPMI-8266 and the immune mechanisms why RPMI-8266 cells escape from the NK cytotoxicity. Methods Detect the cytotoxicity of NK cells against RPMI 8226 cells by LDH release assay at different effect-to-target cell ratios in vitro, K562, high-sensitive with NK cells,was control cell. Test the expression of MHC-± chain-related molecules (MICA/B), human cytomegalovirus glycoprotein UL16-binding protein (ULBP1-3) and HLA -± MHC molecules on K562 and RPMI-8266 cell by flow cytometry. Detect mRNA level of MICA / B and ULBP1 ∼ 3 in K562, RPMI-266, and KIR genotyping of NK cell from 9 cases of healthy volunteers' by PCR method. As the E:T was 20:1, we used AMO-1, BMO-1, M295, M310, M551 and W6/32 mAb to block the effect of cell-surface protein MICA, MICB, ULBP1, ULBP2, ULBP3 and HLA-± in K562 and RPMI-8266 cell respectively, then observe the change of cytotoxicity of NK cells on K562 and RPMI-8266 cell. Results When the E:T was 5:1, cytotoxicity of NK cells on K562 and RPMI-8266 were (29.52 ± 0.27)% and (2.15 ± 0.32)% respectively; As the E:T was 10:1, the cytotoxicity were (36.37 ± 0.78) % and (5.26 ± 0.84)%; As the E:T was 20:1, they were (59.57 ± 1.05)% and (7.63 ± 1.05)%; As the E:T was 40:1, they were (70.64 ± 1.34)% and (10.18 ± 1.53)%. There wre significantly difference of the cytotoxicity of NK cell between on RPMI-8266 and K562 at all E:T ratio(P <0.05); As for different E:T ratio, the cytotoxicity of NK cell on 8266 cells were statistic difference among them (P <0.05). In K562 cell, we detect MICA / B and ULBP 1 ∼ 3 mRNA and protein, but no HLA -± molecules; RPMI-8266 cell expressed MICA / B and ULBP 1 ∼ 3 and HLA -± molecule, but no MICA / B and ULBP 1 ∼ 3. The genotype of KIR were mismatch between RPMI-8266 cell and NK cells from 9 cases of healthy volunteers. The E:T set as 20:1, we used monoclonal antibodies AMO-1, BMO-1, M295, M310 and M551, respectively, to block the effect of MICA, MICB, ULBP1, ULBP2 and ULBP3, killing activity of NK cell on K562 cells significantly decreased, respectively, (40.82 ± 1.47)%, (43.26 ± 2.41)%, (45.42 ± 1.58)%, (50.74 ± 2.16)%, (41.72 ± 1.66)%, compared with the previous block, they were significantly different (P <0.05); The killing activity of NK cell on RPMI-8266 did not significant change after bloking by all monoclonal antibody, they were (5.81 ± 0.72)%, (7.83 ± 0.91)%, (6.77 ± 0.82)%, (8.25 ± 1.46)%, (6.42 ± 0.87)% respectively (P> 0.05); But as we bloked HLA -± molecules with W6/32 monoclonal antibody, the cytotoxicity of NK cell on RPMI-8266 increased to (48.77 ± 4.61)%, there were significant differences between before and after bloking (P <0.05). Conclusion For 8266 cell, the mechanisms of immune escape from NK killing effect may be related to high expression of HLA -± molecule, and did not express the NKG2D ligands MICA / B and ULBP1 ∼ 3 molecules. Disclosures: No relevant conflicts of interest to declare.


2017 ◽  
Vol 20 (2) ◽  
pp. 283-291 ◽  
Author(s):  
Ana Kostic ◽  
Thomas Alexander King ◽  
Feng Yang ◽  
Kuo‐Chen Chan ◽  
George D. Yancopoulos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document